BSE filing, NSE: DEVINE. Summary written from the filing by ALFA Finder's alert engine.
Devine Impex Ltd: key numbers
- Share price
- ₹8.00
- Market cap
- ₹7.63 Cr
- Revenue (annual)
- ₹1.70 Cr
- Net profit (annual)
- ₹0.03 Cr
- P/E (TTM)
- 93.7×Sector 52.0×
- Promoter holding
- 34.54%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Devine Impex Ltd
All →Devine Impex Board Meeting Date
Devine Impex Limited intimated a board meeting on 31 October 2026 to consider unaudited financial results for the quarter and half year ended 30 September 2026. The trading window stays closed until 2 November 2026.
Devine Impex Annual General Meeting
Devine Impex Limited held its 31st Annual General Meeting on September 25, 2026. Shareholders approved the adoption of audited financial statements and the re-appointment of Ms. Manju Jain.
Devine Impex Annual Report
Devine Impex Limited has submitted its Annual Report for the financial year 2025-26. The company's 31st Annual General Meeting is scheduled for September 25, 2026.
Devine Impex Annual General Meeting
Devine Impex Limited has issued a notice for its Annual General Meeting scheduled for September 25, 2026, in Mohali to transact routine business.
Devine Impex Q1 FY27 Results: Turns Profitable, Net Profit ₹3.9 Cr
Devine Impex Ltd reported revenue from operations of ₹26.4 Cr (+116.4% YoY) and net profit of ₹3.9 Cr for Q1 FY27.
- Key figure
- Net profit ₹3.9 Cr
Devine Impex Board Meeting Date
Devine Impex Limited has scheduled a board meeting on August 12, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.